Dr. Nam is currently Head of the Genitourinary Cancer Site Group, Odette Cancer Centre, Sunnybrook Health Sciences Centre. He has expertise in uro-oncology and cancer genetics.

His research interests include the genetic epidemiology of prostate cancer and new biomarker discovery for prostate cancer diagnosis. He holds multiple operating grants in prostate cancer research from the national granting agencies (NCIC and CIHR), and has published a number of papers in the field of prostate cancer genetics and biomarkers. Highlights of his research awards include a CIHR Career Award, a Research Award from the Ministry of Research and Innovation of Ontario, and the Royal College of Physician's and Surgeons Medal Award in Surgery for his work in prostate cancer genetics. He is also the Co-Chair of the American Society of Clinic Oncology (ASCO) Guidelines Committee for the hormonal treatment for prostate cancer.

He has given numerous lectures on prostate cancer biomarkers and genetics in national and international meetings and universities. Dr. Nam's clinical practice primarily consists of the surgical treatment of patients with urologic malignancies, including prostate, bladder, kidney and testicular cancer.

Education:

• MD, 1995, University of Toronto, Canada
• M.Sc., 1999, clinical epidemiology, University of Toronto
• FRCS(C), 2001, Royal College of Physicians and Surgeons of Canada

Appointments and affiliations:

• Associate scientist, evaluative clinical sciences - Odette Cancer Research Program, Sunnybrook Research Institute
• Associate professor, department of surgery, University of Toronto
• Associate member, University of Toronto School of Graduate Studies
• Faculty, department of health policy, management and evaluation, University of Toronto
• Co-chair, American Society of Clinic Oncology (ASCO) Guidelines Committee for the hormonal treatment for prostate cancer

Research foci:

• Prostate cancer
• Genetic epidemiology
• Biomarkers
• Diagnosis
• Prognosis
• Non-experimental methods

Research summary:

Dr. Nam conducts genome-wide association studies for prostate cancer genetics, and evaluative studies on a new prostate cancer screening tool called a nomogram, a statistical model measuring disease risk based on a range of factors including age, family history and race, physical examination and prostate-specific antigen testing.

Awards:

• CIHR Career Award, a research award from the Ministry of Research and Innovation of Ontario
• Royal College of Physician's and Surgeons medal award in surgery, for work in prostate cancer genetics
  

Selected publications:

See current publications list at PubMed.

Related news and stories:

• Avoiding prostate tests because you're afraid of hearing bad news could be deadly mistake (June 5, 2008)
• Prostate cancer risk online tool supports more dialogue (February 4, 2008)
• The penny drops: Sunnybrook Research Institute scientists give Canadian Cancer Society leaders a glimpse of where the money goes (April 4, 2007)
• Hybrid gene targets high relapse risk in prostate cancer patients (January 23, 2007)
• On to the finish line: Sunnybrook scientist sprints forward in a bid to improve the course for prostate cancer testing (January 9, 2007)